K152733 is an FDA 510(k) clearance for the FFRct. This device is classified as a Coronary Vascular Physiologic Simulation Software (Class II - Special Controls, product code PJA).
Submitted by HeartFlow, Inc. (Redwood City, US). The FDA issued a Cleared decision on January 13, 2016, 113 days after receiving the submission on September 22, 2015.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1415. A Coronary Vascular Physiologic Simulation Software Device Is Intended To Aid In The Identification Of Functionally Significant Cardiovascular Disease..